Potential application of a liquid biopsy based on sensitive methylated SEPT9 as a prognostic marker in hepatocellular carcinoma patients treated with molecular targeted agents.
Potential application of a liquid biopsy based on sensitive methylated SEPT9 as a prognostic marker in hepatocellular carcinoma patients treated with molecular targeted agents.
复制标题
基于敏感甲基化 SEPT9 的液体活检作为分子靶向药物治疗的肝细胞癌患者的预后标志物的潜在应用。
DOI：
--
复制
发表时间：
2021
期刊：
影响因子：
--
通讯作者：
Takahiro Yamasaki.
中科院分区：
文献类型：
--
作者：
Issei Saeki;Yurika Yamauchi;Yutaka Suehiro;Hiroaki Nagano;Mototsugu Shimokawa;Taro Takami;Takahiro Yamasaki.
